Infusion set and injector device for infusion set

- Unomedical A/S

An infusion set having an infusion part for insertion into a patient and a connector for connecting the infusion part with a medical device through a tube is provided. The connector is axially displaceable relative to the infusion part. The infusion part includes an adhesive support, a base part with a first set of guiding means and at least two retention devices for locking the connector to the infusion part, a cannula extending from the base part and being in fluid communication with a cavity. The cavity is further adapted to receive a second cannula extending from the connector where the second cannula is in fluid communication with the tube. The infusion set further includes a second set of guiding means that are adapted to fit with the first set of guiding means and at least two arms. The retention devices extend from an upper surface of a main surface of the base part and the arms include means corresponding to the retention members.

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

This application claims priority to Danish Patent Application No. PA 200400493, filed Mar. 26, 2004 and U.S. Provisional Application No. 60/556,863, filed Mar. 26, 2004.

TECHNICAL FIELD

The invention relates to an infusion set for an intermittent or continuous administration of a therapeutical substance, such as insulin and an injector device for an infusion set. An infusion set comprises an infusion part with a cannula to penetrate the skin of a person and a connector for connecting the infusion part with a medical device preferably a medical delivery device such as an insulin pump.

An infusion set has in its assembled form a substantially planar rear side and a relatively large width compared to its thickness, thus allowing it to lie flat on the patient's skin and thereby minimizing the discomfort of carrying the infusion set.

The infusion part is placed in the patient for a longer and not specified time period while the connector is supposed to be connected and disconnected from time to time. Hereby it is possible for the patient to disconnect from the medical device, move around and at a later point re-connect to the medical device. Further it is possible to shift between different medical devices using the same infusion part and thereby there is only need for one penetration of the skin which provides less discomfort to the patient.

The injector device according to the present invention is especially directed towards situations where patients wants to or has to insert the infusion part by themselves without the assistance of educated personnel.

BACKGROUND

U.S. Pat. No. 5,522,803 discloses an infusion set having an infusion part and a connector. The infusion part comprises a soft plastic cannula in liquid communication with a cavity for receiving a needle from a connector, two sloping guiding holes and two retention devices; and the connector comprises a cannula, two square guiding pins and two arms with a hooking part for gripping the retention device of the infusion part and operating in the main plane of the infusion part.

A lot of patients e.g. insulin patients have to or may desire to insert an infusion device or to place a subcutaneous sensor or the like themselves. For some persons it is a troublesome process to perform the skin penetration themselves, they therefore need a device which assists them in this process and thereby making the process less problematic.

U.S. Pat. No. 6,572,586B1 discloses an infusion set for administration of a fluid to a subcutaneous layer and include a cannula housing adapted for mounting onto a patient's skin and a needle housing for connection to the cannula housing. The needle housing has a pair of flexible sidewalls and a resilient band connected to the sidewalls. The resilient band is lockably engage able with the cannula housing thereby securing the housings together, and the resilient band is releasable from the cannula housing when pressing the sidewalls toward each other to deform the resilient band. A hollow needle extends out of a main body of the needle housing for delivering fluid to the cannula from a fluid source. The walls of the needle housing extend beyond a distal end of the hollow needle to prevent needle contact with contaminated surfaces an inadvertent injury.

In both of these infusion sets two arms are formed along the sides of the connector part and the movement performed to unrelease the connector from the infusion part is in both cases pressing the two arms together. Compared to these to constructions the present invention is of a more simple form and also the locking mechanism according to the invention allows for the user to actually see when the arms are unlocked, especially if the infusion part and the connector are toned in different colors.

Given that the infusion part is supposed to be connected and especially disconnected several times with the connector it is important that this operation is painless and simple to perform.

The document US 2003/0225373 discloses an insertion device for inserting an infusion part or a sensor into a patient. The device comprises a housing, a coil spring, a safety device and part for angling the insertion into the patient. However the apparatus is relatively complicated to manufacture industrially and further the device has to be loaded manually by the patient by a rather complicated procedure.

WO 03/026728 A1 discloses an injector device comprising a housing, a spring, a slidable bar, a locking mechanism and a needle.

SUMMARY OF THE INVENTION

The object of the invention is to provide an infusion set with a coupling mechanism which can be connected and separated with as less discomfort to the patient as possible, and which infusion set is also easy for the patient to find out and to operate.

It is also an object of the invention to provide an improved insertion device which is easy to manufacture and which is suitable for being delivered in a loaded form or at least being easier to load. Especially elderly people, who can have some motor problems, need an insertion device which exists in a pre-loaded form.

According to the invention there is provided an infusion set comprising an infusion part for insertion into a patient and a connector for connecting the infusion part with a medical device through a tube. The connector is axially displaceable relative to the infusion part, said infusion part comprising an adhesive support, a base part with a first set of guiding means and at least two retention devices for locking the connector to the infusion part, a cannula extending from said base part and being in fluid communication with a cavity which is optionally covered with a membrane, said cavity being further adapted to receive a second cannula extending from the connector, which second cannula is in fluid communication with the tube, a second set of guiding means adapted to fit with the first set of guiding means and at least two arms where the retention devices are extending from the upper surface of the main surface of the base part and the arms comprise means corresponding to the retention means.

The above described infusion set is easier to disconnect and will seem safer to use for the patient than previously known infusion sets. All that is needed to separate the connector from the infusion part is a slight simultaneous pressure on the two arms of the connector and the user will be able to see how the connection/disconnection between the infusion part and the connector takes place.

With the term cavity is meant the inner lumen of the cannula or the extension of the cannula.

In a preferred embodiment the connector is symmetrical both around the main plain of the connector and around the plane being perpendicular to the main plane and being parallel to the central axis, thus allowing the connector to be connected to the infusion part no matter which of the main sides is facing upwards. This results in an easier operation of the infusion set.

The arms of the connector can appropriately be provided with gripping means for getting a better grip of the connector. Examples of such gripping means could be but are not limited to rims, grooves, recesses, and a roughened surface optionally of another material than the connector itself, preferably recesses are used. This results in a safer and more comforting operation of the infusion set since the risk that the fingers slip during handling resulting in unintended movements of the infusion part and the cannula is reduced.

In one embodiment of the invention the connector has a reduced material content e.g. in the form of at least one groove, preferably at least two grooves, placed where the arms are connected to the central part of the connector comprising the second set of guiding means (8), thus allowing the arms of the connector to move perpendicular to the base part while the second set of guiding means are stationary. This makes it possible to disconnect the connector from the infusion part by lifting the arms instead of pressing them towards each other. Hereby it is achieved that connection/disconnection can be performed in a manner which at the same time reduces the stresses in the material during the operation, eases the operation of the locking mechanism and reduces the patient's unpleasantness during the connection/release of the connector.

In another embodiment retention devices are positioned on a particularly flexible part of the base part. The flexible part can be provided by choosing an appropriate material for the base part or by providing very thin parts of material between the retention parts and the center of the base part, but preferably the base part of the infusion part has at least two cuttings forming at least two flaps. The formed flexible parts are able to in an elastic manner to move out of the main plane of the infusion part. Hereby the same advantages during connection/release as described above are obtained.

In a preferred embodiment the cannula of the infusion part penetrates the adhesive support, thus stabilizing the position of the infusion part relative to the point of skin penetration to an even greater extend. Further this minimizes the risk that the cannula is accidently withdrawn from the patient.

In a preferred embodiment the adhesive support is a plaster.

In a preferred embodiment the infusion part and the connector are made from two different plastics materials, such as two different types of polypropylene.

In a preferred embodiment there is a visual difference in the toning of the connector and the base part of the infusion part. Hereby it is achieved that it is easier for the patient to see the separation line between the two units resulting in an easier operation of the locking mechanism.

In a preferred embodiment the retention devices are in form of at least two steps placed on either the infusion part or the connector and a matching carving in the other part. Preferably the step has a side with a triangular shape thus forming the step as a sloping hill. Preferably the retention devices are placed on the infusion part and the matching carvings are placed in the connector's arms.

In a preferred embodiment the tube is a flexible plastics material which preferably is connected with the rest of the connector by means of glue.

Preferably the medical delivery device is a drug delivery device such as an insulin delivery device e.g. in the form of an insulin pump.

The cannula of the connector can be a hard cannula, preferably a metal cannula such as a steel cannula. Also the cannula of the connector can be made of a plastics material and/or being blunt.

In a preferred embodiment the cannula is a soft cannula preferably a soft cannula made of a plastics material. Preferred plastics materials for the soft cannula are materials which are sufficiently flexible to bend, when the patient moves and sufficiently rigid to avoid kinking, closing off the drug supply. Further the material must be compatible with medical use i.e. irritation of the skin must be kept at a minimum, being non-toxic it must not decompose in the body, etc. Thermoplastic elastomers (TPE) are a type of material which fulfils these requirements. Examples of such useful elastomers are: polyester ethers, ECDEL, styrene based TPE, olefin based TPE, urethane based TPE, ester based TPE, amid based TPE, polyolefins and silicone rubbers. In a preferred embodiment the material is selected from the group consisting of polypropylene, C-FLEX™, mixtures of C-FLEX™ and polypropylene, LUPOLEN™ 1840H, LUPOLEN™ 3020D, PELLETHANE™ 2363-75D, PELLETHANE™ 2363-55D, TECOTHANE™ and CARBOTHANE™.

In a preferred embodiment the infusion part and the connector are made of polypropylene.

Given that the infusion part is supposed to be connected and especially disconnected several times with the connector it is important that the cannula of the connector is guided safely into the cavity of the infusion part and that the cannula in the disconnected situation is protected as much as possible. It is therefore a further object of the invention to provide an infusion set with an improved guiding mechanism and with an improved protection of the connector cannula.

In a preferred embodiment the connector cannula is extending from the central part of the connector and being placed in a withdrawn position relative to the front of the central part and at least one of the first set of guiding means comprises at least two stabilizing fins.

The above described invention provides an infusion set with an improved protection of the cannula of the connector thus allowing the connector to be connected and disconnected from the infusion part more times than in the previously known infusion sets.

A lot of patients e.g. insulin patients have to or may desire to insert an infusion device or to place a subcutaneous sensor or the like themselves. For some persons it is a troublesome process to perform the skin penetration themselves, they therefore need a device which assists them in this process thereby making the process less problematic.

The advantage in essentially vertical insertion is that it is easier to control the dept of the needle penetration and thereby the dept of the cannula. This is important in self-insertion of the infusion part.

According to the invention an injector device is provided for the subcutaneous introduction of a cannula of an infusion part into the skin of a patient. The injector device comprises a housing, a back and longitudinally extending guiding means, a member which is longitudinally slidable within the housing, an insertion needle for insertion in the cavity of said cannula, a spring located between the back of the housing and the longitudinally slidable member, locking means for maintaining the spring in a compressed state and release means for disengaging the locking means characterized in that the device further comprises a pivoting member which can be swung from a position in which the pivoting member allows for insertion of the needle into a position in which the pivoting member embraces the needle.

The insertion device according to this invention is easy to handle in a safe way before, during and after use, even if the user has reduced dexterity in the hands. Also the user can choose an essentially vertical insertion which makes it easier to control the dept of the needle penetration and thereby the insertion dept of the cannula. This is important in self-insertion of the infusion part. Besides the injector is of a very simple construction which makes it possible to reduce costs of production.

The insertion needle can during insertion be unreleasably attached to the slidable member, unreleasably attached to the infusion part thereby being the cannula or the insertion needle can be a separate unit which the user removes after insertion.

In a preferred embodiment the pivoting member is fastened to the slidable member. This makes production of the unit simpler, and also the pivoting member will need to be shorter than if the pivoting member was fastened to the housing. If the pivoting member is fastened to the slidable member, the position where the pivoting member allows for insertion of the needle is preferably in an angle v where v≈45° or larger in order for the pivoting member to be bend backwards when touching the user, preferably v≈90° or larger in order for the pivoting member not to hit the user during insertion. The angle v is the angle between the central axis of the injection device which is parallel to the insertion needle, and the pivoting member.

In a preferred embodiment the insertion device has means for temporarily fixing the pivoting member in an essentially right angle relative to the housing thus stabilizing the insertion device in an essentially vertical position relative to the skin to be penetrated prior to penetration. This is particularly relevant for patients with motor problems since they can have problems to control the insertion angle.

Preferably the housing has means for getting a better grip of the injector device. Examples of such means could be but are not limited to rims, grooves, recesses, a roughened surface optionally of another material than the housing itself, preferably recesses are used

There will be different possibilities for placing the pivoting member in the position where it embraces the needle but in a preferred embodiment the pivoting member embraces the needle when the slidable member is in a forward position and the spring is in a released state. Often when using injection devices in connection with insertion of infusion sets the user is supposed to bring the insertion needle back into the housing in order to protect the surroundings from the used insertion needle. This means the users has to work against the spring force, which was pushing the needle forward during insertion, and at the same time the user has to avoid the used needle, when bringing it back into the housing. This can be quite difficult for a user which might have reduced dexterity of the hands and fingers. According to the present invention it will be quite easy for the user to secure the insertion needle as turning the relatively large pivoting member does not call for the use of strength.

In one embodiment the insertion needle is destroyed and secured as the pivoting member is placed in a final position embracing the needle. This will make it safe to dispose of the used insertion device with ordinary garbage.

In one embodiment the pivoting arms are also the locking means and it has a tab functioning as disengaging means.

In another embodiment there is separate locking means and disengaging means. Preferably the pivoting member then still have a tab for securing the arm in a position parallel to the axis of the housing until it is desired to swing the pivoting member to the position in which it embraces the needle.

Preferably the pivoting member embraces the needle in a first position being parallel to the main axis of the injector device then it is swung into a second position being essentially orthogonal to said main axis and then finally swung into a position in which it embraces the needle.

In a preferred embodiment the pivoting member is swung from the position essentially orthogonal to said main axis, 180 degrees to another position embracing the needle and being secured in this position said position also being essentially orthogonal to the main axis. Optionally the needle is destroyed in the process and secured in the pivoting member.

In another preferred embodiment the infusion part to be inserted is provided with an adhesive support unreleasably fastened to the infusion part and having an adhesive surface, which adhesive surface is provided with a release liner.

In this embodiment the pivoting member can have fixing means for releasably fastening a part of the adhesive support to the pivoting member. This construction assures that the adhesive support is folded in an appropriate way during insertion, which results in that the adhesive support will turn a part of the adhesive surface towards the user's skin, when the infusion part is inserted.

In another preferred embodiment the release liner of the adhesive support can also have one or more projecting parts. Describing parts as projecting from the release liner means that the parts are not necessarily in contact with the adhesive surface of the adhesive support, the projecting part or parts extend beyond the part of the release liner being in protecting contact with the adhesive surface. One of the projecting parts can be fastened unreleasably to the housing in order to at least partly have the release liner removed from the adhesive support during insertion of the needle. The total removal of the release liner will take place after insertion of the needle when the injector device is taken away for disposal and the release liner will—as it is still attached to the injection device—be removed and disposed off together with the used injector device.

In a more preferred embodiment the release liner comprises at least two separate pieces, and each piece has at least one projecting part. This makes it possible to remove the release liner automatically during insertion without the release liner coming into conflict with the insertion needle.

Preferably the projecting part of the first piece of release liner is attached to the pivoting member during insertion and the projecting part of the second piece of release liner is attached to the housing during insertion. This embodiment makes it easier for the user to remove the release liner during/after insertion and at the same time the adhesive surface of the adhesive support is completely protected before insertion.

In a preferred embodiment of the invention the pivoting member of the injector device further has means for temporarily fixing the adhesive support of the infusion part. Hereby it is achieved that the adhesive support does not fold in an unsuitable manner during insertion of the infusion part.

Preferably the injector device comprises means for stopping the slidable member in its most forward position preferably in form of a stopping tab.

BRIEF DESCRIPTION OF THE DRAWINGS

In the following the invention will be described in further details with reference to the figures.

FIG. 1 shows one embodiment of an infusion set where the infusion part and the connector are unified.

FIG. 2 shows one embodiment of the infusion set where the infusion part and the connector are separated.

FIG. 3 shows the same embodiment of the separated infusion set as in FIG. 2 from a different angle.

FIG. 4 shows a second embodiment of a separated infusion set from a first angle.

FIG. 5 shows the second embodiment of the infusion set from a different angle.

FIG. 6 shows a first embodiment of an injector device separated from the infusion part.

FIG. 7 shows the first embodiment of the injector device joined with the infusion part.

FIG. 8 shows the first embodiment of the injector device joined with the infusion part.

FIG. 9 shows the first embodiment of the injector device where the pivoting member is embracing the needle.

FIG. 10 shows the first embodiment of the injector device in the loaded and secured position before injection.

FIG. 11 shows the first embodiment of the injector device in the loaded position from a second angle.

FIG. 12 shows a second embodiment of the injector device in a loaded and secured state.

FIG. 13 shows the second embodiment of the injector device in a ready to use state.

FIG. 14 shows the second embodiment of the injector device after insertion of the needle and before removing the injector from the infusion part.

FIG. 15 shows the second embodiment of the injector device after separating the injector from the infusion part.

FIG. 16 shows the second embodiment of the injector device after the pivoting arm has been positioned to embrace the needle.

FIG. 17 shows the second embodiment of the injector device after the pivoting arm has been positioned to embrace the needle seen from another angle.

FIG. 18 shows an infusion set placed on the skin.

FIG. 19 shows the second embodiment of the injector device together with a credit card.

FIG. 20 shows a third embodiment of the injector device.

FIG. 21A-D shows assembling of the infusion part and injector device according to the third embodiment.

FIG. 22A-B shows the third embodiment of the injector device prepared for insertion.

FIG. 23A-B shows the adhesive support of the infusion part hooked to the slidable member.

FIG. 24A shows the injector device after insertion with an infusion part and FIG. 24B shows the injector device after insertion without the infusion part.

FIG. 25 shows the third embodiment of the injector device after insertion and embracing the needle.

FIG. 26 shows a third embodiment of an infusion part placed on a mounting pad with two separate pieces of release liner.

FIG. 26A-D shows the different steps when injecting the infusion part.

FIGS. 27A-E and 28A-E show the different steps when using the injector device for injecting the infusion part.

 DETAILED DESCRIPTION OF THE INVENTION

FIG. 1-3 illustrates an embodiment of an infusion set. The infusion set comprises an infusion part (0B) and a connector (0A). The infusion part (0B) comprises a base part (2) having a main plane which, when the infusion set is attached to a patient, is essentially parallel to the skin of the patient, and a shoulder part (2a) protecting the connector part (0A) from being released unintentionally. Said base part (2) comprises a first set of guiding means (13) which in this case has the form of two stabilizing fins. The base part further comprises two retention devices (4) extending from the upper surface of the base part in this case in form of two steps. Mounted on the inner surface of the infusion part is an adhesive support (1) which in this case is a plaster. A cannula (5) is extending from the base part (2) and is penetrating the adhesive support (1) being in fluid communication with a central cavity (3). The cannula (5) is preferably a soft cannula but could also be made of metal. The cavity (3) optionally being covered by a membrane is adapted to receive a second cannula (6) extending from the connector. In the embodiment shown in FIG. 2-5 the second cannula (6) is extending from the central part of the connector and is placed in a retracted position relative to the front of the central part. In this embodiment the base part (2) has two cuttings (12) creating two flaps on which the retention devices (4) are mounted. The connector (0A) comprises two arms (9) having four carvings (10) adapted to fit with the retention devices (4). The connector (0A) is symmetrical around the main plane and around the plane perpendicular to the main plane and parallel to the main axis thus allowing the connector to match with the base part in two ways. The cannula (6) is in fluid communication with the tube (7) which provides the connection to a medical device such as an insulin pump. In this embodiment the central part of the connector has a second set of guiding means (8) in form of two grooves placed symmetrically around the main plane of the connector. In this embodiment the connector further has gripping means (11) in form of recesses. The gripping means 11 are optional and can be selected from the group consisting of rims, grooves, recesses or a roughened surface optionally of another material than the connector itself

FIGS. 4 and 5 show another embodiment of the invention where the connector has two grooves (14) which in this case are placed symmetrically around the main plane of the connector. However it is not necessary for the grooves to be places symmetrically around the main plane since they are not coupling with the infusion part.

Whether the infusion set is intended to be inserted manually or by an injector the infusion part (0B) and the connector (0A) are delivered to the user as two separate units in sterile packages. When inserted manually the infusion part (0B) will at delivery be combined with a needle unit with the same locking and guiding means (8) as the connector. The needle unit is provided with an insertion needle extending from the central front which insertion needle at delivery extends through and beyond the end of the cannula (5). The needle unit's only function will be to penetrate the user's skin where after the needle unit is removed and replaced with the connector (0A) leaving the cannula (5) subcutaneous.

The connector (0A) can be connected to a luer coupling member through the tube (7). Through the luer coupling it is possible to administer a suitable therapeutical substance, such as insulin from a pump. The connector can also be a sort of closing part with a suitable entrance for an inserting needle of a syringe. Such a closing part can stay in position for up till three days while the user can have medication, e.g. insulin injected through the entrance in order to reduce trauma to the skin caused by repeated penetration of the skin.

It is important for the user that it is easy to change i.e. to engage and to disengage the infusion part (0B) and the connector (0A) even when the user has reduced dexterity. The present invention complies with this purpose as the movement used to unlock the infusion part (0B) from the connector (0A) is pressing the connector between the first finger and the thumb which is simple and easily performed movement. Also the oppositely directed forces from respectively the first finger and the thumb pushing toward each other, are not only used to unlock the device but is also used when pulling the connector away from the infusion part (0B). In order to make it easier to disengage the connector (0A) the arms (9) can be made very flexible, either by choosing a soft and flexible material or by making the fastening of the arms (9) to the central part more or less rigid e.g. by varying the size of the grooves (14) on the shoulder of the connector (0A).

Although the arms (9) are very flexible the danger of accidently pulling the connector away from the infusion part when positioned on the skin of the user is quite small as the device has to be exposed to a simultaneous pressure from both sides.

Another advantage of the invention according to the present invention is that only a very small amount of material need to be used when producing the infusion part. The infusion part (0B) can be reduced to:

    • a slim central part comprising the cannula (5), the cavity (3) and guiding means (13),
    • a shoulder part (2a) connected to the central part and protecting the ends of the movable arms (9) of the connector when the connector is engaged with the infusion part, and
    • a base part (2) which has been reduced to two arms connected to the central part which arms are provided with the retention means (4).

FIG. 6-11 shows a first embodiment of an injector device (29) which can be used for injection of the infusion part (0B) of the infusion set. In FIG. 6 the injector device is separated from the infusion part (0B) and FIG. 7 and 8 show the same injector device (29) joined with an infusion part (0B). The injector device comprises a housing (30) with two longitudinally extending guiding means (31) formed as grooves in this embodiment and a longitudinally slidable member (32) having guiding means (31a), in this embodiment a rim, corresponding to the guiding means (31). A penetrating needle (35) is extending from the front part of the slidable member (32), and the needle (35) is at the end where it is fastened to the slidable member (32) surrounded by guiding means corresponding to the guiding means (13) on the infusion part (0B). The slidable member (32) is capable of moving from a retracted position to a forward position, and is driven from the retracted position to the forward position by a spring (34). The spring is located between the slidable member (32) and the back (33) of the housing. Optionally there is a spring support (37) (FIG. 8) which fits with the back of the housing thereby minimizing the risk of a malfunctioning spring. The injector device further comprises locking means (38) for maintaining the spring in a compressed state and release means (39) for disengaging the locking means. When the locking means (38) are disengaged, the spring (34) drives the slidable member (32) to its forward position, thus introducing the cannula positioned at the front end of the infusion part (0B) into the patient by means of the needle (35). After the introduction of the cannula, the injector device including the insertion needle (35) is withdrawn from the infusion part (0B) leaving the insertion needle in an exposed position. The pivoting member (36) can then be swung into a position where it embraces the needle (35) as shown in FIG. 9.

FIG. 10 and FIG. 11 show the same embodiment of the injector device in a loaded and secured position. Part of the pivoting member (36) acts as locking means (38). In FIG. 10 it can be seen how the needle (35) fits into the cannula (5) of the infusion part. The needle (35) will bring the cannula (5) with it during the skin penetration. After penetrating the skin the needle (35) secured to the injector will be withdrawn leaving the cannula inserted in the patient. In FIG. 11 the locking means are shown said locking means are disengaged when the tab (38) is pushed over the edge of the outer side of the back (33) of the housing.

FIGS. 12 to 17 show a second embodiment of the injector device according to the invention where the pivoting member (36) is fastened centrally in relation to the slidable member (32). FIG. 12 shows the injector device in a state where the pivoting member (36) protects the needle prior to injection of the cannula (5) of the infusion part (0B). The figure shows the housing (30) with another type of longitudinally extending guiding means (31), in this case a bar. The housing further has gripping means (40), preferably in the form of recesses, as means for getting a better grip of the injector device.

Centrally positioned release means (39) is shown on one of the main faces of the injector device. The advantage of a one button release mechanism is that the risk of a slanting injection is reduced.

In FIG. 13 is shown an injector device prepared for insertion of the needle. The pivoting member is positioned away from the embracing position in an angle v≈90° in relation to the main axis of the injector device where the main axis is coincident with the insertion needle. The adhesive support (1) is positioned in such manner that the cannula (5) of the infusion part (0B) and the therein positioned needle (35) penetrates the adhesive support through an opening in the release liner. When the pivoting member is positioned essentially perpendicular to the main plane of the injector device it can provide a helping mean for achieving essentially vertical injection of the needle. Further FIG. 13 shows the needle (35) of the injector device inside the cannula (5). In FIG. 14 the injector device is in a released state where the needle (35) would have penetrated the skin. The housing in the embodiment of FIG. 14 has a stopping tab (43) corresponding to a protrusion on the slidable member that keeps the slidable member (32) within the housing (30) thereby making it easier to withdraw the needle since there is no risk that the slidable member slides out of the housing. In FIG. 15 the injector device has been withdrawn, leaving the cannula (5) of the infusion part (0B) inserted in the patient. In FIG. 16 and 17 the pivoting member (36) is in a position where it embraces the needle (35) thereby protecting the surroundings from coming into contact with the used needle (35). In FIG. 18 the infusion part (0B) has been brought from the essentially vertical insertion position to a position essentially parallel to the skin.

FIG. 19 shows the injector device together with a credit card to illustrate the size of the injector device.

In FIG. 20 is shown a third embodiment of the injector device together with an infusion part (0B). This embodiment also has a housing (30) with longitudinally extending guiding means (31) and a longitudinally slidable member (32) of a different construction compared to the two first embodiments. Also the pivoting arm (36) and the spring (34) can be seen in this figure. In this embodiment the stopping tab (43) is placed centrally and has the form of a protrusion raising form the lower side of the housing (30). The release means (39) comprises two buttons placed on each side of the housing (30).

In FIG. 20 and FIG. 21A-D it is shown how the infusion part (0B) along with the slidable member (32) and the spring (34) of the third embodiment fit into the housing (30). The unit (51) shown between the pivoting arm (36) and the insertion part (0B) is an adapter which makes it possible to use a standartd injector for different guiding means (13) on the infusion part (0B).

In FIG. 22A-B is shown fixing means (44) placed on the pivoting member (36). It is possible to temporarily attach a part of the adhesive support (1) to the fixing means in order to secure the position of the adhesive support in such a way that the adhesive surface of the support (1) will be turned towards the skin of the patient. Further release means (39) in the form of two buttons, one on each side of the housing (30), can be seen as well as the protruding stopping tab (43).

FIG. 23A-B shows in further details and without the housing how the adhesive support (1) is hooked to the fixing means (44) due to at least one cutting (46) in the adhesive support (1).

FIG. 24A shows the third embodiment of the injector device with an infusion part after insertion and 24B shows the injector device after insertion and after the injector device has been removed from the insertion part (0B).

In FIG. 25 the pivoting member (36) of the injector device is in a position embracing the needle. A locking tab (45) fixes the pivoting arm in this position. This makes certain that the needle stays embraced by the pivoting arm and thereby minimizes the risk of somebody getting hurt by the needle.

FIG. 26 illustrates a third embodiment of an infusion part (0B). The infusion part (0B) comprises a base part (2) which base part (2) comprises a first set of guiding means (13) in the form of two stabilizing fins. The base part (2) comprises two retention devices (4) extending from the upper surface of the base part (2) and having a triangular form. The side of the triangular retention device facing the shoulder part (2a) is approximately perpendicular to the surface of the base part (2) and the side facing away from the shoulder part (2a) is sloping from the top of the retention device (4) to the surface of the base part (2). Mounted on the inner surface of the infusion part (0B) is the adhesive support (1). The cannula (5) is extending from the shoulders (2a) of the base part (2) and is penetrating the adhesive support (1) being in fluid communication with the central cavity (3). The cavity (3) which can be covered by a membrane is adapted to receive a second cannula (6) extending from the connector. In this embodiment the base part (2) has two wide cuttings (12) creating two narrow flaps in the base part (2) on which the retention devices (4) are mounted.

The distance between (I) the side of the retention device (4) closest to the central part of the infusion part (0B) and (II) the central part of the infusion part (0B) defines how far it is possible to move the two arms (9) of the connector in the plane parallel to the base part (2). It is necessary for the corresponding means (10) in the arms (9) of the connector (0A) to be of less width than the distance between (I) and (II). In a preferred embodiment it would also be possible to free the connector (0A) from the infusion part (0B) by moving the arms (9) in a vertical direction away from the base part (2). If this should be possible the arms (9) of the connector need to be adequately flexible where the arms (9) are fixed to the central part of the connector. This can be done either by reducing the thickness of the arms (9) in at least on direction in this area until the desired flexibility is achieved or by choosing to construct the connector part (0A) of a material with a suitable flexibility.

In this embodiment the release liner (41, 42) of the adhesive support (1) is divided into to separated pieces. The first piece (41) is protecting the part of the adhesive support (1) in front of the cannula (5), and the second piece (42) is protecting the part of the adhesive support being behind the cannula (5) and under the infusion part. During insertion the two pieces are separated whereby the part of the adhesive in front of the cannula is bent up and the adhesive side of the adhesive support (1) is exposed around the cannula. The first piece (41) is either pulled back by the user or is attached to one side of the injector device; the second piece (42) is attached to the opposite side of the injector device.

In FIG. 26A-D the cycle of use for the injector device is illustrated.

When the infusion set is delivered to the patient together with the injector device, the infusion part (0B) and the connector (0A) are packed separately and under sterile conditions, and the infusion part (0B) is placed in the injector device (FIG. 26A). When the user wants to insert the infusion part (0B), the user pulls the pivoting arm and turns the arm perpendicularly to the housing (30) (FIG. 26B). In this position the needle (35) placed on the slidable member (32) is exposed and the adhesive support is bend backwards with the adhesive surface turned towards the users skin. The user then pushes the buttons (39) on each side of the housing which releases the spring and pushes the slidable member (32) towards the user's skin (FIG. 26C). The needle (35) will in this position penetrate the skin and place the cannula of the infusion part (0B) subcutaneous. After placing the infusion part (0B) the injector device is removed, and in order to protect the surroundings from the used needle (35) the pivoting arm (36) is turned approximately 180° to an angle w≈90° perpendicular to the main axis of the injector device, where it embraces the needle and make it safer to dispose of the device.

FIGS. 27A-E and 28A-E also illustrates the cycle of use of the injector device seen respectively from the upper (FIG. 27) and the lower (FIG. 28) side of the injector device.

In FIGS. 27A and 28A the device is in a first state, which is the state the device would normally be delivered to the patient in, under sterile conditions. In this state the pivoting arm (36) is in a position where it embraces the needle (35) and the angle v between the main plane of the injector device and the pivoting arm is approximately 0°, if the release means (39) should unintentionally be pressed in this situation two protruding tabs (48) will prevent the slidable member (32) from being pushed forward.

In FIGS. 27B and 28B the device is prepared for use by lifting the pivoting arm (36) backwards thereby exposing the insertion needle (35) and also in this embodiment lifting the part of the release liner (41) which is attached to the pivoting arm (36), exposing the underlying adhesive support (1). In this position the pivoting arm (36) allows for insertion of the needle and is in an angle v to main plane of the injector device where 90°≦v≦180°, and in this position the injector device would be placed against the patient's skin.

In FIGS. 27C and 28C the release means (39) has been pressed and has released the spring (34). The spring has pushed the slidable member (32) forward until the slidable member was stopped by two stopping tabs (43). In this position the insertion needle (35) has penetrated the patient's skin and a part (this part covers an area around the needle in the full breadth of the adhesive support) of the adhesive surface of the adhesive support (1) is in contact with the patient's skin. In FIG. 28C it is shown how the second part (42) of the release liner is attached to the housing (30) and still covers the adhesive surface when the slidable member (32) is pushed forward.

In FIGS. 27D and 28D it is shown what happens when the injector device is removed from the patient, leaving the infusion part (0B) inserted subcutaneously. The user frees the first part (41) of the release liner from the pivoting arm (36) and then when pulling the injector device away the second part (42) of the release liner is also pulled away, exposing the adhesive surface of the adhesive support (1) and making it possible for the user to press the adhesive support towards the skin and thereby securing the infusion part (0B).

Finally after withdrawal of the insertion needle which in this embodiment is attached to the slidable member (32) in the injector device, it is shown in FIGS. 27E and 28E how the pivoting member (36) is placed in a position where it is embracing the needle thereby protecting the surroundings from getting stung. In order to get into this position the pivoting arm (36) is turned approximately 180° from the position in FIGS. 27D and 28D, and the angle w between the main plane of the injector device and the pivoting arm (36) is approximately 90°.

Claims

1. An assembly for the subcutaneous introduction of a cannula of an infusion part into a patient, the assembly comprising:

an infusion part comprising:
an adhesive support;
a base part including at least two retention devices configured to releasably lock a connector to the infusion part, the retention devices extending from an upper surface of a main surface of the base part; and
a cannula extending from the base part and being in fluid connection with a cavity of the infusion part, the cavity being adapted to receive a second cannula extending from the connector and through which a therapeutical substance is administrable; and
an injector device comprising an insertion needle configured to releasably receive the infusion part, the insertion needle extending at least partially through at least a portion of the cannula to insert the cannula into the skin of the patient;
wherein at least a portion of the adhesive support is connected to a portion of the injector device; and a pivoting member connected to the injector device and pivotable from an insertion position into a protection position, the insertion position configured to allow insertion of the needle into the patient and the protection position configured to protect the needle wherein the pivoting member embraces the needle.

2. The assembly of claim 1, wherein the retention devices are positioned at flexible parts of the base part.

3. The assembly of claim 2, wherein the base part comprises at least two flaps on which the retention devices are positioned.

4. The assembly of claim 1, wherein the cannula passes through the adhesive support.

5. The assembly of claim 1, wherein the retention devices each comprise a step.

6. The assembly of claim 1, wherein the retention devices have a triangular shape.

7. The assembly of claim 1, wherein the cannula comprises thermoplastic elastomers (TPE).

8. The assembly of claim 7, wherein the thermoplastic elastomer is selected from the group consisting of polyester ethers, ECDEL, styrene based TPE, olefin based TPE, urethane based TPE, ester based TPE, amid based TPE, polyolefins and silicone rubbers.

9. The assembly of claim 1, wherein the infusion part comprises polypropylene.

10. The assembly of claim 1, wherein a projecting part of a release liner of the adhesive support is fastened to the injector device.

11. The assembly of claim 1, further comprising a release liner of the adhesive support, the release liner comprising at least two separate pieces.

12. The assembly of claim 11, wherein a portion of each piece of the release liner is attached to the injector device during insertion.

13. An assembly for the subcutaneous introduction of a cannula of an infusion part into a patient, the assembly comprising:

an infusion part comprising: an adhesive support; a base part including at least two retention devices configured to releasably lock a connector to the infusion part, the retention devices extending from an upper surface of a main surface of the base part; and a cannula extending from the base part and being in fluid connection with a cavity of the infusion part; and
an injector device comprising: a housing comprising a longitudinally extending guide; a slidable member adapted to longitudinally slide relative to the housing; a needle connected to the slidable member, the needle configured for insertion at least partially through the cannula to insert the cannula into the skin of the patient, a spring located between a back portion of the housing and the longitudinally slidable member; and a pivoting member connected to the injector device and pivotable from an insertion position into a protection position, the insertion position configured to allow insertion of the needle into the patient and the protection position configured to protect the needle wherein the pivoting member embraces the needle.

14. The assembly of claim 13, wherein the pivoting member is fastened to the slidable member.

15. The assembly of claim 14, wherein the insertion position of the pivoting member is an insertion angle between about 45° and about 180°, the insertion angle measured in relation to a central axis of the needle.

16. The assembly of claim 14, wherein the insertion position of the pivoting member is an insertion angle between about 80° and about 180°, the insertion angle measured in relation to a central axis of the needle.

17. The assembly of claim 14, wherein the insertion position of the pivoting member is an insertion angle between about 90°, the insertion angle measured in relation to a central axis of the needle.

18. The assembly of claim 13, wherein the pivoting member is placed substantially parallel to the housing when the pivoting member is in the position where the pivoting member embraces the needle.

19. The assembly of claim 13, wherein the pivoting member is placed in an embracing angle with respect to the housing between about 0° and about 180° when the pivoting member is in the position where the pivoting member embraces the needle.

20. The assembly of claim 13, wherein the pivoting member is placed in an embracing angle with respect to the housing between about 90° and about 180° when the pivoting member is in the position where the pivoting member embraces the needle.

21. The assembly of claims 13, wherein the pivoting member can embrace the needle when the slidable member is in a forward position and the spring is in a released state.

22. The assembly of claim 13, wherein the needle is destroyed and secured in the pivoting member in the protection position.

23. The assembly of claim 13, wherein the assembly further comprises locking means for maintaining the pivoting member in the protection position.

24. The assembly of claim 13, the pivoting member has fixing means for releasably fastening a part of the adhesive support to the pivoting member.

25. The assembly of claim 13, wherein a projecting part of a release liner of the adhesive support is unreleasably fastened to the housing.

26. The assembly of claim 13, further comprising a release liner of the adhesive support, the release liner comprising at least two separate pieces.

27. The assembly of claim 26, wherein each piece of the release liner is attached to the pivoting member during insertion and the projecting part of the second piece of the release liner is attached to the housing during insertion.

Referenced Cited
U.S. Patent Documents
643544 February 1900 Simmons
1838825 December 1931 Goldstein
1991103 February 1935 King
2047010 July 1936 Dickinson
2295849 September 1942 Kayden
2319731 May 1943 Garrett
2533731 December 1950 Gomberg
2630803 March 1953 Baran
2690529 May 1954 Lindblad
2730099 January 1956 Sullivan
2839060 June 1958 Ormo
2936141 May 1960 Rapata
2952420 September 1960 Von Hoorn
3055361 September 1962 Ballard
3074541 January 1963 Roehr
3107785 October 1963 Roehr
3154080 October 1964 Rowan et al.
3317166 May 1967 Janssen
3545286 December 1970 Stenstrom
3547119 December 1970 Hall et al.
3610240 October 1971 Harautuneian
3648999 March 1972 Bauer
3783996 January 1974 Gerard et al.
3814097 June 1974 Ganderton et al.
3831729 August 1974 Howard
3840011 October 1974 Wright
3865236 February 1975 Rycroft
3942528 March 9, 1976 Loeser
3986508 October 19, 1976 Barrington
4014328 March 29, 1977 Cluff et al.
4022205 May 10, 1977 Tenczar
4146113 March 27, 1979 Gavel
4150798 April 24, 1979 Aragon
4188950 February 19, 1980 Wardlaw
4201406 May 6, 1980 Dennehey et al.
4227528 October 14, 1980 Wardlaw
4267836 May 19, 1981 Whitney et al.
4306705 December 22, 1981 Svenson
4315505 February 16, 1982 Crandall et al.
4334551 June 15, 1982 Pfister
D267199 December 7, 1982 Koenig
4365630 December 28, 1982 McFlarlane
4400861 August 30, 1983 Parker
4406042 September 27, 1983 McPhee
4458344 July 3, 1984 Coogler
4472024 September 18, 1984 Konomura et al.
4473369 September 25, 1984 Lueders et al.
4500312 February 19, 1985 McFarlane
4517971 May 21, 1985 Sorbonned
4530695 July 23, 1985 Phillips et al.
4531686 July 30, 1985 Shaw
4531937 July 30, 1985 Yates
4563177 January 7, 1986 Kamen
4576846 March 18, 1986 Noel
4606735 August 19, 1986 Wilder et al.
4610469 September 9, 1986 Wolff-Mooij
4616790 October 14, 1986 Beltran
4619349 October 28, 1986 Braun
4635683 January 13, 1987 Nielsen
4637404 January 20, 1987 Gessman
4662873 May 5, 1987 Lash et al.
4682702 July 28, 1987 Gach
4713059 December 15, 1987 Bickelhaupt et al.
4734092 March 29, 1988 Millerd
4755173 July 5, 1988 Konopka et al.
4758020 July 19, 1988 Boyd
4800629 January 31, 1989 Ikeda
4802638 February 7, 1989 Burger et al.
4817603 April 4, 1989 Turner et al.
RE32922 May 16, 1989 Levin et al.
4838871 June 13, 1989 Luther
4840613 June 20, 1989 Balbierz
4850974 July 25, 1989 Bickelhaupt et al.
4878897 November 7, 1989 Katzin
4895570 January 23, 1990 Larkin
D306500 March 6, 1990 Brahler
4913369 April 3, 1990 Lia et al.
4917669 April 17, 1990 Bonaldo
4935010 June 19, 1990 Cox et al.
4950163 August 21, 1990 Zimble
4950252 August 21, 1990 Luther et al.
4978338 December 18, 1990 Melsky et al.
4982842 January 8, 1991 Hollister
4986817 January 22, 1991 Code
4994042 February 19, 1991 Vadher
4994045 February 19, 1991 Ranford
5011475 April 30, 1991 Olsen
5024662 June 18, 1991 Menes et al.
5067496 November 26, 1991 Eisele
5077872 January 7, 1992 Guthammar
5083757 January 28, 1992 Barsky
5092853 March 3, 1992 Couvertier, II
5098389 March 24, 1992 Cappucci
5112313 May 12, 1992 Sallee
5116319 May 26, 1992 Van den Haak
5116324 May 26, 1992 Brierley et al.
5116325 May 26, 1992 Paterson
5121751 June 16, 1992 Panalletta
5129884 July 14, 1992 Dysarz
5134593 July 28, 1992 Logan et al.
5134594 July 28, 1992 Woo
5137516 August 11, 1992 Rand et al.
5137524 August 11, 1992 Lynn et al.
5141496 August 25, 1992 Dalto et al.
5147319 September 15, 1992 Ishikawa et al.
5147375 September 15, 1992 Sullivan et al.
5161681 November 10, 1992 Kemp et al.
5163915 November 17, 1992 Holleron
5176650 January 5, 1993 Haining
5176662 January 5, 1993 Bartholomew et al.
5188314 February 23, 1993 Peters
5188611 February 23, 1993 Orgain
RE34223 April 13, 1993 Bonaldo
5222947 June 29, 1993 D'Amico
5232454 August 3, 1993 Hollister
5236143 August 17, 1993 Dragon
5240199 August 31, 1993 Peters
5248301 September 28, 1993 Koenig et al.
5256152 October 26, 1993 Marks
5257980 November 2, 1993 Van Antwerp et al.
5265822 November 30, 1993 Shober, Jr. et al.
5269799 December 14, 1993 Daniel
5279579 January 18, 1994 D'Amico
5279591 January 18, 1994 Simon
5282793 February 1, 1994 Larson
5300030 April 5, 1994 Crossman et al.
5312359 May 17, 1994 Wallace
5312369 May 17, 1994 Arcusin et al.
5316246 May 31, 1994 Scott et al.
5324302 June 28, 1994 Crouse
5342319 August 30, 1994 Watson et al.
5342324 August 30, 1994 Tucker
5343637 September 6, 1994 Schindler
5350392 September 27, 1994 Purcell et al.
5354280 October 11, 1994 Haber et al.
5366469 November 22, 1994 Steg et al.
5372592 December 13, 1994 Gambale
5376082 December 27, 1994 Phelps
5380067 January 10, 1995 Turvill et al.
5384174 January 24, 1995 Ward et al.
5387197 February 7, 1995 Smith et al.
5388931 February 14, 1995 Carlson
5390669 February 21, 1995 Stuart et al.
5391151 February 21, 1995 Wilmot
5403288 April 4, 1995 Stanners
5405332 April 11, 1995 Opalek
5429607 July 4, 1995 McPhee
5429613 July 4, 1995 D'Amico
5433307 July 18, 1995 Jeppe
5439473 August 8, 1995 Jorgensen
D362718 September 26, 1995 Deily et al.
5449349 September 12, 1995 Sallee et al.
5451210 September 19, 1995 Kramer et al.
5487506 January 30, 1996 Drummond et al.
5490841 February 13, 1996 Landis
5492313 February 20, 1996 Pan et al.
5505709 April 9, 1996 Funderburk et al.
5507730 April 16, 1996 Haber et al.
5519167 May 21, 1996 Kunimoto et al.
5520654 May 28, 1996 Wahlberg
5522803 June 4, 1996 Teisson-Simony
5527287 June 18, 1996 Miskinyar
5533974 July 9, 1996 Gaba
5540709 July 30, 1996 Ramel
5545143 August 13, 1996 Fischell
5545152 August 13, 1996 Funderburk et al.
5554130 September 10, 1996 McDonald et al.
5558650 September 24, 1996 McPhee
5562636 October 8, 1996 Utterberg
5575777 November 19, 1996 Cover et al.
5584813 December 17, 1996 Livingston et al.
5591188 January 7, 1997 Waisman
5599309 February 4, 1997 Marshall et al.
5599315 February 4, 1997 McPhee
5599318 February 4, 1997 Sweeney et al.
5628765 May 13, 1997 Morita
5643214 July 1, 1997 Marshall et al.
5643216 July 1, 1997 White
5643220 July 1, 1997 Cosme
5662617 September 2, 1997 Odell et al.
5665071 September 9, 1997 Wyrick
5665075 September 9, 1997 Gyure et al.
5676156 October 14, 1997 Yoon
5681323 October 28, 1997 Arick
5695476 December 9, 1997 Harris
5704920 January 6, 1998 Gyure
5709516 January 20, 1998 Peterson et al.
5714225 February 3, 1998 Hansen et al.
5738641 April 14, 1998 Watson et al.
5741288 April 21, 1998 Rife
5752923 May 19, 1998 Terwilliger
5810835 September 22, 1998 Ryan et al.
5817058 October 6, 1998 Shaw
5820598 October 13, 1998 Gazza et al.
5833666 November 10, 1998 Davis et al.
D402538 December 15, 1998 Wagter et al.
5843001 December 1, 1998 Goldenberg
5848990 December 15, 1998 Cirelli et al.
5851197 December 22, 1998 Marano et al.
5858001 January 12, 1999 Tsals et al.
5865806 February 2, 1999 Howell
5873540 February 23, 1999 Hardin
5899886 May 4, 1999 Cosme
5913846 June 22, 1999 Szabo
5915640 June 29, 1999 Wagter et al.
5919167 July 6, 1999 Mulhauser et al.
5925032 July 20, 1999 Clements
5947931 September 7, 1999 Bierman
5947935 September 7, 1999 Rinehart et al.
5951523 September 14, 1999 Osterlind et al.
5954643 September 21, 1999 VanAntwerp et al.
5957892 September 28, 1999 Thorne
5968011 October 19, 1999 Larsen et al.
5975120 November 2, 1999 Novosel
5980488 November 9, 1999 Thorne
5980506 November 9, 1999 Mathiasen
5984224 November 16, 1999 Yang
5984897 November 16, 1999 Petersen et al.
5992787 November 30, 1999 Burke
D417733 December 14, 1999 Howell et al.
6017328 January 25, 2000 Fischell et al.
D421119 February 22, 2000 Musgrave et al.
6039629 March 21, 2000 Mitchell
6042570 March 28, 2000 Bell et al.
6045533 April 4, 2000 Kriesel et al.
6050976 April 18, 2000 Thorne et al.
6056718 May 2, 2000 Funderburk et al.
6056726 May 2, 2000 Isaacson
6074371 June 13, 2000 Fischell
6077244 June 20, 2000 Botich et al.
6086008 July 11, 2000 Gray et al.
6086575 July 11, 2000 Mejslov
6090068 July 18, 2000 Chanut
6093172 July 25, 2000 Funderburk et al.
6093179 July 25, 2000 O'Hara et al.
6099503 August 8, 2000 Stardella
6105218 August 22, 2000 Reekie
6120482 September 19, 2000 Szabo
6123690 September 26, 2000 Mejslov
6132755 October 17, 2000 Eicher et al.
6159181 December 12, 2000 Crossman et al.
6183464 February 6, 2001 Sharp et al.
6191338 February 20, 2001 Haller
6193694 February 27, 2001 Bell et al.
6219574 April 17, 2001 Cormier et al.
6221058 April 24, 2001 Kao et al.
6248093 June 19, 2001 Moberg
6293925 September 25, 2001 Safabash et al.
6302866 October 16, 2001 Marggi
6319232 November 20, 2001 Kashmer
6322535 November 27, 2001 Hitchins et al.
6322808 November 27, 2001 Trautman et al.
6334856 January 1, 2002 Allen et al.
6355021 March 12, 2002 Nielsen et al.
6379335 April 30, 2002 Rigon et al.
D456692 May 7, 2002 Epstein
6387076 May 14, 2002 Van Landuyt
6450992 September 17, 2002 Cassidy, Jr.
6488663 December 3, 2002 Steg
6517517 February 11, 2003 Farrugia et al.
6520938 February 18, 2003 Funderburk et al.
D472316 March 25, 2003 Douglas et al.
D472630 April 1, 2003 Douglas et al.
6572586 June 3, 2003 Wojcik
6579267 June 17, 2003 Lynch et al.
6582397 June 24, 2003 Alesi et al.
6595962 July 22, 2003 Perthu
6607509 August 19, 2003 Bobroff et al.
6607511 August 19, 2003 Halseth et al.
6620136 September 16, 2003 Pressly, Sr. et al.
6629949 October 7, 2003 Douglas
6645182 November 11, 2003 Szabo
6685674 February 3, 2004 Douglas et al.
6702779 March 9, 2004 Connelly et al.
6726649 April 27, 2004 Swenson et al.
6736797 May 18, 2004 Larsen et al.
6749589 June 15, 2004 Douglas et al.
6790199 September 14, 2004 Gianakos
6805686 October 19, 2004 Fathallah et al.
6811545 November 2, 2004 Vaillancourt
6814720 November 9, 2004 Olsen et al.
6824530 November 30, 2004 Wagner et al.
6824531 November 30, 2004 Zecha, Jr. et al.
6830562 December 14, 2004 Mogensen et al.
6837877 January 4, 2005 Zurcher
6840922 January 11, 2005 Nielsen et al.
6880701 April 19, 2005 Bergeron et al.
6916017 July 12, 2005 Noe
6923791 August 2, 2005 Douglas
6926694 August 9, 2005 Marano-Ford et al.
6939331 September 6, 2005 Ohshima
6949084 September 27, 2005 Marggi et al.
6979316 December 27, 2005 Rubin et al.
7018344 March 28, 2006 Bressler et al.
7056302 June 6, 2006 Douglas
7214207 May 8, 2007 Lynch et al.
7303543 December 4, 2007 Maule et al.
20010004970 June 28, 2001 Hollister et al.
20010016714 August 23, 2001 Bell et al.
20010021827 September 13, 2001 Ferguson et al.
20010039401 November 8, 2001 Ferguson et al.
20010041875 November 15, 2001 Higuchi et al.
20020022855 February 21, 2002 Bobroff et al.
20020068904 June 6, 2002 Pluth et al.
20020072720 June 13, 2002 Hague et al.
20020077599 June 20, 2002 Wojcik
20020107489 August 8, 2002 Lee
20020111581 August 15, 2002 Sasso
20020145073 October 10, 2002 Swanson
20020156424 October 24, 2002 Suzuki et al.
20020156427 October 24, 2002 Suzuki et al.
20020161332 October 31, 2002 Ramey
20020169419 November 14, 2002 Steg
20020173748 November 21, 2002 McConnell et al.
20020173769 November 21, 2002 Gray et al.
20020183688 December 5, 2002 Lastovich et al.
20020189688 December 19, 2002 Roorda
20020193737 December 19, 2002 Popovsky
20020193744 December 19, 2002 Alesi et al.
20030014018 January 16, 2003 Giambattista et al.
20030060781 March 27, 2003 Mogensen et al.
20030069548 April 10, 2003 Connelly et al.
20030105430 June 5, 2003 Lavi et al.
20030109829 June 12, 2003 Mogensen et al.
20030125669 July 3, 2003 Safabash et al.
20030125678 July 3, 2003 Swenson et al.
20030130619 July 10, 2003 Safabash et al.
20030139704 July 24, 2003 Lin
20030158520 August 21, 2003 Safabash et al.
20030176843 September 18, 2003 Wilkinson
20030181863 September 25, 2003 Davis et al.
20030181868 September 25, 2003 Swenson
20030181873 September 25, 2003 Swenson
20030181874 September 25, 2003 Bressler et al.
20030187394 October 2, 2003 Wilkinson et al.
20030187395 October 2, 2003 Wilkinson et al.
20030199823 October 23, 2003 Bobroff et al.
20030216686 November 20, 2003 Lynch et al.
20030225373 December 4, 2003 Bobroff et al.
20030225374 December 4, 2003 Mathiasen
20030229308 December 11, 2003 Tsals et al.
20030229316 December 11, 2003 Hwang et al.
20040002682 January 1, 2004 Kovelman et al.
20040006316 January 8, 2004 Patton
20040026840 February 12, 2004 Eckel et al.
20040044306 March 4, 2004 Lynch et al.
20040049159 March 11, 2004 Barrus et al.
20040068231 April 8, 2004 Blondeau
20040087913 May 6, 2004 Rogers et al.
20040111068 June 10, 2004 Swenson
20040112781 June 17, 2004 Hofverberg et al.
20040116865 June 17, 2004 Bengtsson
20040138612 July 15, 2004 Shermer et al.
20040138620 July 15, 2004 Douglas et al.
20040143216 July 22, 2004 Douglas et al.
20040143218 July 22, 2004 Das
20040158202 August 12, 2004 Jensen
20040158207 August 12, 2004 Hunn et al.
20040162518 August 19, 2004 Connelly et al.
20040171989 September 2, 2004 Horner et al.
20040178098 September 16, 2004 Swenson et al.
20040186446 September 23, 2004 Ohshima
20040199123 October 7, 2004 Nielsen
20040204687 October 14, 2004 Mogensen et al.
20040204690 October 14, 2004 Yashiro et al.
20040215151 October 28, 2004 Marshall et al.
20040220528 November 4, 2004 Garcia, Jr.
20040236284 November 25, 2004 Hoste et al.
20040238392 December 2, 2004 Peterson et al.
20040243065 December 2, 2004 McConnell et al.
20040254433 December 16, 2004 Bandis et al.
20040260235 December 23, 2004 Douglas
20040260250 December 23, 2004 Harris et al.
20050035014 February 17, 2005 Cane
20050043687 February 24, 2005 Mogensen et al.
20050075606 April 7, 2005 Botich et al.
20050101910 May 12, 2005 Bowman et al.
20050101932 May 12, 2005 Cote et al.
20050101933 May 12, 2005 Marrs et al.
20050107743 May 19, 2005 Fangrow, Jr.
20050113761 May 26, 2005 Faust et al.
20050119637 June 2, 2005 Lundgren et al.
20050124936 June 9, 2005 Mogensen et al.
20050159709 July 21, 2005 Wilkinson
20050215979 September 29, 2005 Kornerup et al.
20050251098 November 10, 2005 Wyss et al.
20050277892 December 15, 2005 Chen
20050283114 December 22, 2005 Bresina et al.
20060015063 January 19, 2006 Butikofer et al.
20060030815 February 9, 2006 Csincsura et al.
20060041224 February 23, 2006 Jensen
20060173413 August 3, 2006 Fan
Foreign Patent Documents
893 296 December 1953 DE
1 053 541 March 1959 DE
26 20 009 December 1977 DE
28 03 509 August 1979 DE
28 03 509 August 1979 DE
37 15 965 January 1988 DE
196 31 921 March 1997 DE
298 18 311 March 1999 DE
299 05 072 September 1999 DE
298 18 311 November 1999 DE
19847143 January 2000 DE
101 06 074 September 2000 DE
299 21 406 January 2001 DE
101 06 074 June 2002 DE
299 21 406 November 2002 DE
37 22 893 June 1988 DK
38 23 447 February 1996 DK
196 10 692 September 1997 DK
198 47 143 January 2000 DK
100 49 001 April 2002 DK
0 188 014 October 1985 EP
0 239 244 February 1987 EP
0 290 176 November 1988 EP
0 298 521 September 1990 EP
0 451 040 October 1991 EP
0 184 231 January 1992 EP
0 475 857 March 1992 EP
0 544 837 June 1993 EP
0 633 039 July 1994 EP
0 651 662 May 1995 EP
0 714 631 June 1996 EP
744 183 November 1996 EP
0 747 006 December 1996 EP
0 688 232 December 1998 EP
0 884 108 December 1998 EP
0 916 361 May 1999 EP
0 931 560 July 1999 EP
0 956 879 November 1999 EP
0 615 768 December 1999 EP
1 045 145 October 2000 EP
1 060 757 December 2000 EP
1 086 718 March 2001 EP
1 125 593 August 2001 EP
1 167 765 January 2002 EP
0 775 501 June 2002 EP
0 894 216 July 2003 EP
1 329 233 July 2003 EP
1 380 315 January 2004 EP
0 956 879 July 2004 EP
576 849 August 1924 FR
576849 August 1924 FR
2 611 013 August 1988 FR
2725902 October 1994 FR
2 733 915 November 1996 FR
2733915 November 1996 FR
2 781 617 January 2000 FR
2781617 January 2000 FR
478803 January 1938 GB
591730 March 1946 GB
906574 September 1962 GB
1 268 575 March 1972 GB
1 403 034 August 1975 GB
2 224 808 May 1990 GB
2 270 552 March 1994 GB
5326062 December 1993 JP
05326062 December 1993 JP
7051251 November 1995 JP
9217584 September 1997 JP
2000-59877 February 2000 JP
3140740 February 2000 JP
2000059877 February 2000 JP
3140740 March 2001 JP
2002-028246 January 2002 JP
1017427 November 2002 NL
WO 87/06474 November 1987 WO
WO 93/03787 March 1993 WO
WO 93/05840 April 1993 WO
WO 94/20160 September 1994 WO
WO 95/28327 October 1995 WO
WO 96/32981 October 1996 WO
WO 96/35472 November 1996 WO
WO 98/09065 March 1998 WO
WO 98/58693 December 1998 WO
WO 99/07435 February 1999 WO
WO 99/33504 July 1999 WO
WO 99/36009 July 1999 WO
WO 99/56802 November 1999 WO
WO 99/61815 December 1999 WO
WO 00/02614 January 2000 WO
WO 00/03757 January 2000 WO
WO 00/44324 August 2000 WO
WO 01/04507 January 2001 WO
WO 01/30419 May 2001 WO
WO 01/68180 September 2001 WO
WO 01/81785 November 2001 WO
WO 01/93926 December 2001 WO
WO 02/46080 June 2002 WO
WO 02/066854 August 2002 WO
WO 02/081012 October 2002 WO
WO 02/094352 November 2002 WO
WO 02/100457 December 2002 WO
WO 02/102442 December 2002 WO
WO 02/068014 January 2003 WO
WO 03/015860 February 2003 WO
WO 03/026728 April 2003 WO
WO 2004/030726 April 2004 WO
WO 2004/087240 October 2004 WO
WO 2005/004973 January 2005 WO
Patent History
Patent number: 7648494
Type: Grant
Filed: Mar 21, 2005
Date of Patent: Jan 19, 2010
Patent Publication Number: 20050215979
Assignee: Unomedical A/S (Birkeroed)
Inventors: Grete Kornerup (Vipperød), Lasse Wesseltoft Mogensen (Søborg), Magnus Walter Göransson (Malmö )
Primary Examiner: Nicholas D Lucchesi
Assistant Examiner: Quynh-Nhu H Vu
Attorney: Brinks Hofer Gilson & Lione
Application Number: 11/084,893